NovaBridge Biosciences
VIS-101
wet AMD
Date
TBD
Phase 3 readout · Date TBD estimated
What's at stake
Phase 3 trial results for VIS-101 in wet AMD are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“Initiate global Phase 3 program in 2027”